Company news
Oruka Therapeutics, Inc. (NASDAQ:ORKA) news
Oruka Therapeutics, Inc. news releases on 6ix. Latest, Apr 18, 2022: ARCA biopharma Establishes Special Committee of the Board of Directors
Press releases — page 2
ARCA biopharma Establishes Special Committee of the Board of Directors
April 17, 2022
ARCA biopharma Announces 2021 Financial Results and Provides Corporate Update
March 13, 2022
ARCA biopharma Announces Completion of Enrollment in Phase 2b ASPEN-COVID-19 Clinical Trial Evaluating rNAPc2 as a Potential Treatment for Patients Hospitalized with COVID-19
December 1, 2021
ARCA biopharma to Present at the Q4 Virtual Investor Summit on November 17th
November 8, 2021
ARCA biopharma Announces Third Quarter 2021 Financial Results and Provides Corporate Update
November 1, 2021
ARCA biopharma Announces Enrollment of First International Patient in Phase 2b Clinical Trial Evaluating rNAPc2 as a Potential Treatment for COVID-19
September 15, 2021
ARCA biopharma to Present at the Q3 Virtual Investor Summit on August 18th
August 15, 2021
ARCA biopharma Announces Submission of PCT Patent Application for the Treatment of Coronavirus Infection and Associated Coagulopathy with rNAPc2
August 8, 2021
ARCA biopharma Announces Second Quarter 2021 Financial Results and Provides Corporate Update
August 3, 2021
Gencaro Atrial Fibrillation Phase 2B Results Selected for Publication in Circulation: Arrhythmia and Electrophysiology
July 27, 2021
ARCA biopharma Announces rNAPc2 COVID-19 Patent Assignment Agreement
July 6, 2021
ARCA biopharma Announces First Quarter 2021 Financial Results and Provides Corporate Update
May 10, 2021
ARCA biopharma Announces C. Jeff Dekker to be Appointed Chief Financial Officer
May 2, 2021
ARCA biopharma Announces 2020 Financial Results and Provides Corporate Update
March 17, 2021
ARCA biopharma Announces First Patients Enrolled in ASPEN-COVID-19 Phase 2b Clinical Trial Evaluating rNAPc2 (AB201) as a Potential Treatment for COVID-19
December 14, 2020
ARCA biopharma Announces Location Change for 2020 Annual Meeting of Stockholders
December 8, 2020
AB201 Development as a Potential Treatment for COVID-19 Receives U.S. FDA Fast Track Designation
November 22, 2020
ARCA biopharma Announces Third Quarter 2020 Financial Results and Provides Corporate Update
November 1, 2020
ARCA biopharma Announces FDA Approval of IND Application for AB201 as a Potential Treatment for COVID-19
October 6, 2020
ARCA biopharma Announces Promotion of Chief Medical Officer and Vice President, Regulatory Affairs & Quality
October 4, 2020
ARCA biopharma Announces Submission of IND Application to U.S. FDA for AB201 as a Potential Treatment for COVID-19
September 20, 2020
ARCA Biopharma Announces Completion of FDA Pre-IND Consultation Under Coronavirus Treatment Acceleration Program for AB201 as a Potential Treatment for Severe COVID-19
August 11, 2020
Arca Biopharma Announces Second Quarter 2020 Financial Results and Provides Corporate Update
August 4, 2020
SARS-CoV-2 Cell Entry Mechanisms in Intact Human Heart Published in JACC: Basic to Translational Science by University of Colorado Anschutz Medical Campus and ARCA biopharma Investigators
July 6, 2020
ARCA biopharma Announces Closing of $6.1 Million Registered Direct Offering
June 2, 2020
ARCA Biopharma Announces $9.4 Million Registered Direct Offering
May 31, 2020
ARCA biopharma Announces AB201 Development Program for Treatment of COVID-19 Associated Coagulopathy
May 27, 2020
Clinical Data Evaluating Gencaro for the Treatment of Atrial Fibrillation in Heart Failure Patients Featured in Three Presentations at the 2020 Heart Rhythm Scientific Sessions
May 6, 2020
ARCA Biopharma Announces First Quarter 2020 Financial Results And Provides Corporate Update
May 5, 2020
ARCA biopharma Announces Fiscal Year 2019 Financial Results and Provides Corporate Update
February 17, 2020
ARCA Biopharma Announces Third Quarter 2019 Financial Results and Provides Corporate Update
November 5, 2019
ARCA Biopharma President and CEO Dr. Michael Bristow to Present at HFSA 2019 Excellence in Translational Science Symposium
September 11, 2019
Arca Biopharma Announces Gencaro Atrial Fibrillation Clinical Data Selected for Presentation at HFSA 2019 Scientific Meeting
September 10, 2019